Skip to main content
logo
Kailera Therapeutics, Inc. (KLRA)
NASDAQ: KLRA · Real-Time Price · USD
17.54
-0.78 (-4.26%)
Aug 20, 2026, 3:30 PM EDT - Market open

Kailera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Market Capitalization
2,274--
Market Cap Growth
---
Enterprise Value
1,112--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Debt / Equity Ratio
0.010.020.00
Net Debt / Equity Ratio
-1.04-1.01-1.02
Net Debt / EBITDA Ratio
3.714.067.15
Net Debt / FCF Ratio
5.195.250.94
Quick Ratio
11.0311.8325.35
Current Ratio
11.1112.0225.70
Return on Equity (ROE)
--36.90%-
Return on Assets (ROA)
--22.73%-
Return on Capital Employed (ROCE)
-27.80%-24.50%-14.30%
SEC Filings: 10-K · 10-Q